Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer von Lindsay, C R, Le Moulec, S, Billiot, F, Loriot, Y, Ngo-Camus, M, Vielh, P, Fizazi, K, Massard, C, Farace, F

Volltext

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas von Farace, F, Massard, C, Vimond, N, Drusch, F, Jacques, N, Billiot, F, Laplanche, A, Chauchereau, A, Lacroix, L, Planchard, D, Le Moulec, S, André, F, Fizazi, K, Soria, J C, Vielh, P

Volltext

A fatal allo- and immune-mediated thrombocytopenia with a PD-L1 inhibitor von Leroy, L., Lafarge, X., Blouin, L., Bijou, F., Durrieu, F., Olivier, E., Le Moulec, S.

Volltext

Circulating Biomarkers in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus in the Pre-nephrectomy Setting von Mauge, L., Phan, L., Benhamouda, N., Galy-Fauroux, I., Badoual, C., Topart, D., Thiery-Vuillemin, A., Le Moulec, S., Guillot, A., Cessot, A., Mejean, A., Albiges, L., Tartour, E., Fournier, L., Helley, D., Oudard, S.

Volltext

Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs platinum-based chemotherapy (CT) based on clinical characteristics in patients with metastatic (m) NSCLC: Res... von Cho, B.C., Reinmuth, N., Lee, K.H., Ahn, M.-J., Luft, A., Van den Heuvel, M., Dols, M. Cobo, Smolin, A., Vicente, D., Moiseyenko, V., Antonia, S.J., Moulec, S. Le, Robinet, G., Natale, R., Garon, E.B., Nakagawa, K., Liu, F., Thiyagarajah, P., Peters, S., Rizvi, N.A.

Volltext

Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III,... von Trédaniel, J., Barlési, F., Le Péchoux, C., Lerouge, D., Pichon, É., Le Moulec, S., Moreau, L., Friard, S., Westeel, V., Petit, L., Carré, O., Guichard, F., Raffy, O., Villa, J., Prévost, A., Langlais, A., Morin, F., Wislez, M., Giraud, P., Zalcman, G., Mornex, F.

Volltext

Prognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI) von Hendriks, L., Henon, C., Auclin, E., Mezquita, L., Ferrara, R., Audigier Valette, C., Mazieres, J., Lefebvre, C., Le Moulec, S., Duchemann, B., Le Pechoux, C., Botticella, A., Ammari, S., Gazzah, A., Caramella, C., Adam, J., Planchard, D., De Ruysscher, D., Dingemans, A.-M.C., Besse, B.

Volltext

Management of a progressing prostate cancer: results of a national study von Rozet, F, Roupret, M, Hennequin, C, Massard, C, Blanchard, P, Le Moulec, S

Volltext

2538 Response to cabazitaxel in patients with metastatic castrationresistant prostate cancer (mCRPC) poorly responding to docetaxel von Angelergues, A, Bellmunt, J, Efstathiou, E, Gonzalez, I, Gyftaki, R, Delanoy, N, Ozguroglu, M, Flechon, A, Guillot, A, Le Moulec, S, Castellano, D, Esteban, E, Munarriz, J, Campos Balea, B, Ardavanis, A, Stefanou, D, Oudard, S

Volltext

2541 Updated results of the FLAC European database of metastatic castration resistant prostate cancer (mCRPC) patients (pts) treated with life extending therapies in post-docetaxel... von Oudard, S, Angelergues, A, Efstathiou, E, Gonzalez, I, Gyftaki, R, Delanoy, N, Ozguroglu, M, Flechon, A, Guillot, A, Le Moulec, S, Castellano, D, Esteban, E, Munarriz, J, Campos Balea, B, Ardavanis, A, Stefanou, D, Bellmunt, J

Volltext

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC von Socinski, Mark A, Jotte, Robert M, Cappuzzo, Federico, Orlandi, Francisco, Stroyakovskiy, Daniil, Nogami, Naoyuki, Rodríguez-Abreu, Delvys, Moro-Sibilot, Denis, Thomas, Christian A, Barlesi, Fabrice, Finley, Gene, Kelsch, Claudia, Lee, Anthony, Coleman, Shelley, Deng, Yu, Shen, Yijing, Kowanetz, Marcin, Lopez-Chavez, Ariel, Sandler, Alan, Reck, Martin

Volltext

Neuroendocrine carcinoma of the digestive tract: a literature review von Jacob, J, Chargari, C, Helissey, C, Ferrand, F-R, Ceccaldi, B, Le Moulec, S, Bauduceau, O, Fayolle, M, Védrine, L

Volltext

Fever and cancer: components of diagnosis for optimal management von Moussaid, Y, Bertaux, M, Chargari, C, Helissey, C, Le Moulec, S, Errihani, H, Vedrine, L

Volltext

7051 POSTER Bicalutamide in Combination With Vandetanib or Placebo in Patients With Castration-refractory Metastatic Prostate Cancer Without Any Clinical Symptom Related to Disease... von Loriot, Y, Houédé, N, Le Moulec, S, Hennequin, C, Eymard, J.C, Beuzeboc, P, Oudard, S, Culine, S, Carrasco, A. Tisseron, Fizazi, K

Volltext

1375P Sequential ctDNA profiling in patients with advanced non-small cell lung cancer: An interim analysis of the COPE randomized study von Italiano, A., Phan, L., Le Moulec, S., Grellety, T., Lecaille, C., Cochin, V., Schneider, S., Sabatini, M., Leroy, L., Tasseel, A., Cabart, M., Chomy, F., Laizet, Y., Soubeyran, I., Crombe, A., Cousin, S.

Volltext

V070 - Robot-assisted retroperitoneal lymph node dissection and vena cava thrombectomy for residual masses of germ cell tumor von Khaddad, A., Michiels, C., Paganelli, L., Dupitout, L., Gross-Goupil, M., Ravaud, A., Alezra, E., Estrade, V., Capon, G., Bladou, F., Robert, G., Le Moulec, S., Bernhard, J.C.

Volltext

Robot-assisted retroperitoneal lymph node dissection and vena cava thrombectomy for residual masses of germ cell tumor von Khaddad, A., Michiels, C., Paganelli, L., Dupitout, L., Gross-Goupil, M., Ravaud, A., Alezra, E., Estrade, V., Capon, G., Bladou, F., Robert, G., Le Moulec, S., Bernhard, J.C.

Volltext

1757P Preliminary results from AVENANCE, an ongoing, noninterventional real-world, ambispective study of avelumab first-line (1L) maintenance treatment in patients (pts) with local... von Barthelemy, P., Thibault, C., Voog, E., Eymard, J-C., Ravaud, A., Flechon, A., Abraham Jaillon, C., Hilgers, W., Le Moulec, S., Chasseray, M., Pouessel, D., Amela, Y.E., Lorgis, V., Nicolas, E., Kazan, E., Denechere, G., Solbes, M-N., Lambert, P., Loriot, Y.

Volltext

Cancer chemotherapy of the upper aerodigestive tract von Védrine, L, Chargari, C, Le Moulec, S, Fayolle, M, Ceccaldi, B, Bauduceau, O

Volltext

IDO-1 and PD-L1 predict response to immunotherapy in advanced non small cell lung cancer: An NGS and multiplex IHC analysis von Leroy, L., Massé, J., Adam, J., Brouste, V., Signolle, N., Soubeyran, I., Velasco, V., Khalifa, E., Lortal, B., Italiano, A., Besse, B., Le Moulec, S.

Volltext